Stem Cells And The Origins Of Barrett's Esophagus:Identification Of Novel Biomarkers And Gene Signatures In Barrett's Esophagus
This Project is designed to identify biologically-based and clinically-useful biomarkers of
tissue at risk for neoplastic progression as well as of response to ablation therapy. These
results will result in improved risk stratification in BE and better targeting of resources
for patients who are candidates for ablative therapy, while simultaneously providing key
information regarding the origins of Barrett's esophagus.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Response to therapy
evaulation will be made at 3 month intervals for one year post ablation
one year post ablation
No
Kenneth K Wang, MD
Principal Investigator
Mayo Clinic
United States: Institutional Review Board
11-006510
NCT01568723
January 2012
August 2018
Name | Location |
---|---|
Columbia University | New York, New York 10032-3784 |
University of Pennsylvania Perelman School of Medicine | Philadelphia, Pennsylvania 19104-4311 |